http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20120121184-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K10-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-747 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-66 |
| filingDate | 2011-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20120121184-A |
| titleOfInvention | Antimicrobial Composition Against Methicillin Resistant Staphylococcus Aureus |
| abstract | The present invention relates to the use of lactic acid bacteria, lysates thereof, cultures thereof or extracts thereof having antimicrobial activity against Methicillin resistant Staphylococcus aureus (MRSA). Lactic acid bacteria having antimicrobial activity against MRSA according to the present invention, its lysate, its culture or its extract is guaranteed even if ingested, inhibits the toxicity and inhibits the growth of MRSA, as pharmaceutical, food and feed composition It can be usefully used for the prevention and treatment of MRSA infections. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2988763-A1 |
| priorityDate | 2011-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.